CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-11 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +34,239 | $21.58 | $739K | 557,717 |
| 2026-08-11 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −34,239 | $148.52 | $5.1M | 523,478 |
| 2026-08-11 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −34,239 | 125,000 | ||
| 2026-08-10 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +65,761 | $21.58 | $1.4M | 589,239 |
| 2026-08-10 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −65,761 | $149.11 | $9.8M | 523,478 |
| 2026-08-10 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −65,761 | 159,239 | ||
| 2026-06-23 | Waddill William D. Director | Option exercise 10b5-1 | +9,000 | $16.54 | $149K | 16,825 |
| 2026-06-23 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $117.94 | $1.1M | 7,825 |
| 2026-06-23 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −9,000 | 0 | ||
| 2026-06-10 | Waddill William D. Director | Option exercise 10b5-1 | +3,000 | $11.80 | $35K | 10,825 |
| 2026-06-10 | Waddill William D. Director | Option exercise 10b5-1 | +6,000 | $16.54 | $99K | 16,825 |
| 2026-06-10 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $107.68 | $969K | 7,825 |
| 2026-06-10 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 0 | ||
| 2026-06-10 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −6,000 | 9,000 | ||
| 2026-05-29 | Waddill William D. Director | Option exercise 10b5-1 | +9,000 | $11.80 | $106K | 16,825 |
| 2026-05-29 | Waddill William D. Director | Sale 10b5-1 | −9,000 | $99.64 | $897K | 7,825 |
| 2026-05-29 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −9,000 | 3,000 | ||
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Option exercise 10b5-1 | +75,000 | $21.58 | $1.6M | 598,478 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −75,000 | $100.12 | $7.5M | 523,478 |
| 2026-05-12 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −75,000 | 225,000 |
Page 2 of 29 · 580 trades